• to lessen the potential risk of severe cardiovascular (coronary heart and blood vessel) problems in Grownups with type two diabetes and cardiovascular diseaseWegovy® incorporates semaglutide and really should not be employed with other semaglutide-made up of items or other GLP-one receptor agonist medicines.By 2022 the popularity of Novo's Weg